Knocking Out Brain Tumors with AI and ODS Medical

12 Jul

By Erika Wu, Business Development Representative, LSN

From the early days of his career, Dr. Chris Kent, President & CEO of ODS Medical, knew he wanted to push the limits of brain cancer tumor detection with Artificial Intelligence (AI). ODS Medical is looking to launch their first pivotal clinical trial by mid-2022. Chris is a former RESI AI panelist. Hear what he and the team have been working on this year and register now for RESI AI (September 16-17) and tell your story at the Innovator’s Pitch Challenge!

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: